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AbstrAct
Objectives: The aim of this clinical trial was to evaluate the additional benefit of using guided tis-
sue regeneration (GTR) with autogenous cortical bone (ACB) grafting versus ACB grafting alone for 
the regenerative treatment of intraosseous periodontal defects.
Methods: Via a split-mouth design, 12 patients with chronic periodontitis (five men, seven wom-
en; mean age, 45.3±4.6 years) who had probing pocket depths (PPDs) of ≥6 mm following initial peri-
odontal therapy were randomly assigned to two treatments in contralateral areas of the dentition: a 
combination of ACB grafting and GTR (with a absorbable membrane of polylactic acid) or ACB graft-
ing alone. The compared parameters were preoperative and 6-month postoperative PPDs, clinical 
attachment levels (CALs), and radiographic alveolar bone heights.
Results: Both treatment modalities resulted in significant changes in the postoperative mea-
surements from the preoperative values (P<.01). The reduction in the PPDs, gain in the CALs, and 
gain in the radiographic alveolar bone heights were 4.58±1.08, 4.25±1.06, and 5.50±2.24 mm in the 
patients treated with ACB grafting and GTR and 4.92±1.00, 4.50±0.80, and 5.92±1.83 mm in those 
treated with ACB grafting alone, respectively. The differences between the treatments were not 
statistically significant (P>.05). 
Conclusions: Within the study limitations, both ACB grafting with GTR and ACB grafting alone 
lead to significant improvements in clinical and radiographic parameters at 6 months postopera-
tively. The combined approach does not provide any additional benefit for treating intraosseous peri-
odontal defects. (Eur J Dent 2010;4:403-411)
Key words: Autogenous bone graft; Guided tissue regeneration; Intraosseous defects; Periodon-
tal regeneration.
Gonca Cayir Kelesa 
Mahmut Sumerb 
Burcu Ozkan Cetinkayaa 
Ferda Tutkuna 
S. Burcak Simsekc
   
Effect of Autogenous Cortical Bone 
Grafting in Conjunction with Guided 
Tissue Regeneration in the Treatment of 
Intraosseous Periodontal Defects
a  Ondokuz Mayis University, Faculty of Dentistry, 
  Department of Periodontology, 
  Samsun, Turkey.
b  Ondokuz Mayis University, Faculty of Dentistry, 
  Department of Oral and Maxillofacial Surgery, 
  Samsun, Turkey.
c  Goztepe Oral and Dental Health Center, 
  Istanbul, Turkey.
Corresponding author: 
Dr. Gonca Cayir Keles
Ondokuz Mayis University, Faculty of Dentistry, 
Department of Periodontology 5139 
Samsun, Turkey.
Phone: +90 362 3121919/3017   
Fax: +90 362 4576032   
E-mail: goncakeles@hotmail.comEuropean Journal of Dentistry
404
Periodontitis, an oral infectious disease, is 
characterized by clinical attachment loss, alveo-
lar bone resorption, periodontal pocket formation, 
and gingival inflammation.1,2 One of the main ob-
jectives of periodontal therapy is regeneration of 
the periodontium, including restoration of the al-
veolar bone, cementum, and periodontal ligament 
lost because of periodontitis.3,4 Periodontal regen-
eration can be achieved by guided tissue regen-
eration (GTR),4 which delays the apical migration 
of the gingival epithelium by excluding the gingival 
connective tissue and allows granulation tissue 
derived from the periodontal ligament and osse-
ous tissues to repopulate the space adjacent to 
the denuded root surface through the use of bar-
rier membranes.5 New connective tissue attach-
ment and bone fill, and improved clinical param-
eters have been documented in human biopsy6,7 
and clinical GTR studies,8,9 respectively.
Bone grafting procedures with autogenous 
bone grafts, allografts, xenografts, and alloplasts 
are also used to promote periodontal regenera-
tion.4 Among the different available graft materi-
als, autogenous bone remains the gold standard 
for osseous regeneration.4,10,11 Autogenous bone 
has osteogenic potential, as it contains cells that 
participate in osteogenesis.4,12 Moreover, auto-
grafts are bioabsorbable (they are eventually 
replaced by the patient's own bone),10 nonaller-
genic (they cause minimal tissue reaction with-
out an immunological reaction),4,10 easy to handle, 
and not costly.13 Rapid revascularization occurs 
around autogenous bone graft particles, and the 
graft can release growth and differentiation fac-
tors.4,14 Although autogenous bone grafts present 
some disadvantages, such as the need for second-
ary surgical sites and resulting additional surgi-
cal morbidity,10,15 they can be minimized by using 
intraoral harvested bone.15 The use of the latter 
graft material is however limited by the restricted 
donor sites in the oral cavity for extensive graft-
ing.4,15 
In order to support barrier membranes, pre-
vent collapse, and promote bone formation, GTR 
has often been combined with the placement of 
bone grafts or bone graft substitutes. The effec-
tiveness of the combined procedure for treating 
periodontal intraosseous defects has been evalu-
ated in comparison with the use of GTR alone in 
IntroductIon many studies, which have shown contradictory re-
sults.16-19 Some clinical studies have demonstrated 
better clinical results and bone fill with the com-
bined procedure,16,19 whereas no significant differ-
ence was found between the treatments in other 
studies.17,18 Moreover, few experimental studies 
have reported successful alveolar ridge augmen-
tation by combining autogenous mandibular bone 
grafts  with  nonresorbable  and  resorbable  GTR 
membranes.20,21 One clinical study has shown that 
the combination of an autogenous bone graft and 
a  bioabsorbable  GTR  membrane  is  effective  for 
treating three-wall periodontal defects.22 
Data from both clinical and histological studies 
suggest that periodontal regeneration occurs fol-
lowing treatment with autogenous bone grafts.23-25 
However, a 12-month clinical study has shown that 
autogenous cancellous bone from the jaw com-
pared with open flap debridement is not suitable 
for treating intrabony periodontal defects.26 Note-
worthily, an autogenous cortical bone (ACB) graft, 
sourced from the surgical site adjacent to the in-
traosseous defect, is advantageous as it prevents 
the need for a second surgical site while treating 
intraosseous periodontal defects. Further, the use 
of a physical barrier in addition to an ACB graft 
may enhance the regenerative outcome. The aim 
of this clinical trial was to evaluate the additional 
benefit of using GTR in conjunction with ACB graft-
ing versus ACB grafting alone for the regenerative 
treatment of intraosseous periodontal defects.
MAtErIALs And MEtHods
Experimental design
Two different approaches to treat intraosse-
ous periodontal defects were compared by using 
a split-mouth, randomized, controlled design. 
Randomization was conducted before surgery 
according to the flip of a coin. The same surgical 
and grafting procedures were performed in both 
groups of patients; the application of a bioabsorb-
able GTR membrane was the only difference be-
tween the groups. The clinical and radiographic 
outcomes were measured on the day of surgery 
and at 6 months postoperatively. 
Study population
Patients with chronic periodontitis exhibit-
ing radiographic evidence of bone loss were re-
cruited for the study. For inclusion, the subjects 
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had to have similar interproximal osseous defects 
without furcation involvement in each of the con-
tralateral quadrants including the premolars and 
molars. Third molars with grade III mobility, teeth 
with inadequate endodontic treatment, and/or re-
stored teeth were excluded from the study. The 
exclusion criteria were systemic disease (i.e., dia-
betes mellitus, cancer, HIV, bone metabolic dis-
eases, or disorders that compromise wound heal-
ing), chronic high-dose steroid therapy, radiation 
or immunosuppressive therapy, pregnancy, lacta-
tion, allergy or sensitivity to any drug, and smok-
ing. The subjects had no history of drug therapy for 
the last 6 months before recruitment to the study. 
The enrolled patients signed an informed con-
sent  form  after  receiving  information  about  the 
study. The study protocol and consent forms were 
approved  by  the  University  Institutional  Review 
Board (assignment protocol 06.12.2005/327).
Initial periodontal therapy
The initial periodontal therapy in all the patients 
consisted of oral hygiene instruction, full-mouth 
scaling and root planing, and occlusal adjustment 
when indicated. Four to six weeks following the 
completion of this therapy, a periodontal reevalu-
ation  was  performed  to  determine  the  patient's 
response to the therapy and confirm the need for 
periodontal  surgery.  Furthermore,  the  following 
selection criteria had to be met: 1) probing pocket 
depth (PPD) ≥ 6 mm; 2) radiographic and intrasur-
gical osseous defect depth ≥ 4 mm; 3) two or three 
osseous walls. 
Clinical and radiographic measurements
The PPD and clinical attachment level (CAL) 
were measured and plaque index (PI)27 and gingi-
val index (GI)28 scores were recorded immediately 
before the surgery and at 6 months postoperative-
ly by using a Florida Probe (Florida Probe Corp., 
Gainesville,  FL,  USA).  The  measurements  were 
recorded by the same examiner (intra-examiner 
calibration), who was blinded to the treatments, 
in six areas per tooth: mesiobuccal, distobuccal, 
midbuccal, mesiolingual, distolingual, and midlin-
gual. 
Standardized  radiographs  were  obtained  by 
using  the  parallel  technique  with  a  customized 
film holder prior to the surgery and at 6 months 
postoperatively.29  The  radiographic  defect  angle 
was measured between the two lines representing 
the root surface of the involved tooth and the bone 
Figure 1. Radiographic appearances of an intraosseous defect treated with ACB 
grafting and GTR (CEJ, cementoenamel junction; AB, alveolar bone). A. Before treat-
ment B. After treatment.
Figure 2. Radiographic appearances of an intraosseous defect treated with ACB 
grafting alone (CEJ, cementoenamel junction; AB, alveolar bone). A. Before treat-
ment B. After treatment.
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defect surface.30,31 The linear alveolar bone level, 
between the radiographic cementoenamel junc-
tion (CEJ) and the most apical alveolar bone, was 
determined by using millimeter-scale paper.29 
Surgical procedure
All the operative procedures were performed 
on an outpatient basis under aseptic conditions by 
two experienced periodontal clinicians under lo-
cal anesthesia; one of them performed the surgi-
cal procedure and the other assisted during the 
procedure. Following buccal and lingual intracre-
vicular incisions, full-thickness mucoperiosteal 
flaps were raised to allow access to the intrabony 
defect and facilitate primary closure where pos-
sible. Vertical releasing incisions were made only 
if necessary for better access or to achieve bet-
ter closure of the surgical site. All the granulation 
tissues were removed from the defects, and the 
roots were thoroughly scaled and planed by us-
ing hand and ultrasonic instruments. The surgical 
sites were then rinsed with sterile saline.
During surgery, the depth of the intrabony 
defect was determined as the distance from the 
alveolar bone crest to the bottom of the defect, 
which is calculated as the distance between the 
CEJ and the bottom of the osseous defect minus 
the distance between the CEJ and the most coro-
nal extension of the alveolar bone crest.32 
An adequate amount of particulate cortical 
bone was harvested from the buccal cortical plate 
adjacent to the intraosseous defect by using a 
bone scraper and implanted into the intrabony de-
fect. For the treatment with ACB grafting and GTR, 
Atrisorb (Atrix Laboratories, Inc., Fort Collins, 
CO, USA), an absorbable polylactide membrane, 
was prepared according to the manufacturer's 
instructions and placed over the grafted defects. 
The flaps were repositioned and secured with 4-0 
silk suture material by using the interrupted and 
vertical mattress suturing technique. Primary clo-
sure was obtained in all cases. 
Postoperative care
The patients were prescribed amoxicillin + 
clavulanic acid (2 g/day for 7 days), flurbiprofen 
(200 mg/day for 3 days), and 0.2% chlorhexidine 
gluconate mouth rinse (twice a day for 6 weeks). 
Mechanical tooth cleaning was not allowed in the 
surgical area for the first 6 postoperative weeks. 
The sutures were removed one week after surgery. 
Recall appointments for supragingival profession-
al tooth cleaning and oral hygiene reinforcement 
were scheduled every other week during the first 
two months after surgery and once a month for 
the rest of the study period.
Statistical analysis
A commercially available software program 
(SPSS version 13.0; SPSS, Inc., Chicago, IL, USA) 
was used for statistical analysis. The Shapiro–
Wilk test was used to investigate whether the data 
were normally distributed or not and the Wilcoxon 
signed-rank test was used for intragroup and in-
tergroup comparisons.
The power analysis indicated that 12 defects 
in each treatment modality would be sufficient to 
demonstrate statistical significance at the P<.05 
level with a power of (at least) ≥80%. The data are 
shown as the mean±standard deviation or the me-
dian (range). 
rEsuLts
Twelve patients (five men and seven women) 
aged 45.3±4.6 years (38–52 years) with 24 intraos-
seous defects were treated. The radiographic 
defect angles were intermediate in both the ACB 
graft-treated  group  (30.25±2.14  degrees)  and 
ACB graft with GTR-treated group (29.67±1.83 de-
grees). An analysis of the defect characteristics 
at the baseline revealed no significant differenc-
es between the treatment modalities (P>.05), as 
summarized in Table 1.
Defect healing following both the surgical 
techniques was uneventful. Neither allergic re-
action nor suppuration or abscess formation was 
observed at any surgical site. Further, membrane 
exposure was not detected.  
The PI and GI scores are presented in Table 
2. The GI scores decreased at 6 months postop-
eratively compared with the preoperative data 
(P<.01), but the PI scores were not different from 
the preoperative values (P>.05) in both groups. 
Intergroup comparisons of the preoperative and 
postoperative data showed no significant differ-
ences between the groups (P>.05). 
Intragroup comparisons showed that both 
treatment modalities resulted in significant 
changes in the postoperative measurements 
compared with the preoperative values (P<.01). 
   Autogenous cortical bone graftingOctober 2010 - Vol.4
407
European Journal of Dentistry
The  PPD  reduced  by  4.58±1.08  mm  in  the  ACB 
graft with GTR-treated group and 4.92±1.00 mm 
in the ACB graft-treated group. The preoperative 
CAL improved by 4.25±1.06 and 4.50±0.80 mm in 
the ACB graft with GTR-treated and ACB graft-
treated groups, respectively. Further, the gain in 
radiographic alveolar bone height was 5.50±2.24 
mm in the ACB graft with GTR-treated group and 
5.92±1.83 mm in the ACB graft-treated group (Fig-
ures 1 and 2). No statistically significant difference 
in any clinical parameters was observed between 
the groups (P>.05), as shown in Table 3.
dIscussIon
The results of the present study showed clini-
cal improvement in the clinical and radiographic 
parameters after both regenerative treatments 
without significant differences between the treat-
ment modalities. This result means that the GTR 
protocol did not provide an additional benefit to 
ACB grafting.
Reduction in the PPD and gain in the CAL are 
the most important clinical outcomes of regener-
ative therapy.33 It is well documented that a gain in 
the CAL after any type of regenerative and conven-
tional periodontal treatment is dependent on the 
initial PPD; that is, the deeper the initial PPD, the 
greater is the PPD reduction and clinical attach-
ment gain.8 In addition, the depth of the intrabony 
defect is the determining factor for the maximal 
possible attachment gain.34 In this way, a deeper 
intrabony defect may be related to a greater gain in 
the CAL.8 There were no differences between the 
treatment groups in terms of the initial PPD and 
intrabony defect depth. The gain in the CAL might 
have resulted from periodontal regeneration via 
new attachment or healing characterized by the 
formation of long junctional epithelium between 
the new regenerated tissues and the root sur-
face.35 Histological analysis of regenerative peri-
odontal therapy is important in addition to observ-
ing clinical and radiographic results. As has been 
reported,36 both radiographic interpretations and 
changes in CAL measurements over time are reli-
able for assessing the outcome of intrabony defect 
treatments. In other words, the use of the CAL and 
ACB/GTR* ACB*
Upper/lower teeth 7/5 5/7
Premolar/molar teeth 6/6 5/7
Defect wall component (2-wall/3-wall) 9/3 8/4
Depth of the intrabony defect (mm) 5.00±1.13 5.25±0.87
Defect angle (°) 29.67±1.83 30.25±2.14
Table 1. Preoperative characteristics of intraosseous defects.
Depths of the intrabony defect and defect angles are expressed as the means±standard deviation.
*: No significant difference between the values of the groups (P>.05)
Preoperative Postoperative 6 months Significance (P value)
Plaque index*
ACB/GTR
0.49±0.10 0.45±0.07
0.50 (0.40-0.70) 0.40 (0.40-0.60) >.05
ACB
0.52±0.08 0.48±0.08
0.50 (0.40-0.60) 0.50 (0.40-0.60) >.05
Gingival index*
ACB/GTR
1.18±0.12 0.32±0.09
1.20 (1.00-1.40) 0.30 (0.20-0.50) <.01
ACB
1.13±0.12 0.36±0.09
1.10 (1.00-1.30) 0.35 (0.20-0.50) <.01
Table 2. Plaque index and gingival index scores of intraosseous defects.
Data are expressed as the means±standard deviation and medians (minimum-maximum).
ACB: autogenous cortical bone  GTR: guided tissue regeneration.
*: No significant difference between the values of the groups (P>.05).
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radiographic evaluation are equally indicative of 
the outcome of periodontal therapies. When inter-
preting the findings of the present study, it should 
also be noted that the changes in the CAL are in 
agreement with the gain in the radiographic alveo-
lar bone height. In addition, postsurgical healing 
indicated an excellent soft tissue response to both 
treatments with no adverse complications.
Radiographic changes in the alveolar bone 
height may also be used when a reentry procedure 
is not performed. In the present study, reentry sur-
gery was not performed for ethical reasons and the 
probability of further alveolar bone loss.37 Instead, 
the split-mouth design was used in the same pa-
tient to ensure that the defects were comparable 
and had the same healing potential.
The polylactic acid barrier membrane was se-
lected for GTR because this type of barrier is suc-
cessful in regenerative periodontal therapy38-40 
and shows effective clinical results similar to 
nonabsorbable barriers.41,42 Such a barrier is eas-
ily adaptable to the defect and absorbed by rate-
controlled hydrolysis.40 
Root resorption and ankylosis have been ob-
served in animal and human studies after the use 
of autogenous bone grafts.43,44 However, via an 
experimental study, it was suggested that autog-
enous bone grafts from intraoral sources do not in-
duce ankylosis.4 In the present study, there was no 
evidence of ACB graft-induced root resorption and 
ankylosis, which appears to occur at sites where 
bone formation takes place without regeneration 
of periodontal ligament.45 
The ACB graft used in the present study was ob-
tained from the buccal cortical plate adjacent to the 
intraosseous defect. The use of an ACB graft avoids 
the need for a second surgical region, compared 
with an autogenous bone graft harvested from an 
extraoral or intraoral (e.g., mandibular symphysis, 
maxillary tuberosity) region. Despite the increased 
Preoperative Postoperative 6 months Significance (P value) Difference
PPD*
ACB/GTR
7.75±0.97 3.17±0.58 4.58±1.08
8.0 (6.0-9.0) 3.0 (2.0-4.0) <.01 4.5 (3.0-6.0)
ACB
7.92±1.00 3.00±0.74 4.92±1.00
8.0 (6.0-10.0) 3.0 (2.0-4.0) <.01 5.0 (3.0-6.0)
CAL*
ACB/GTR
8.67±0.78 4.42±0.67 4.25±1.06
9.0 (7.0-10.0) 4.0 (4.0-6.0) <.01 4.5 (3.0-6.0)
ACB
8.67±0.78 4.17±0.72 4.50±0.80
8.5 (8.0-10.0) 4.0 (3.0-5.0) <.01 5.0 (3.0-5.0)
REC*
ACB/GTR
0.92±0.67 1.25±0.62 -0.33±0.49
1.0 (0.0-2.0) 1.0 (0.0-2.0) <.05 0.0 (-1.0-0.0)
ACB
0.75±0.75 1.17±0.83 -0.42±0.51
1.0 (0.0-2.0) 1.0 (0.0-2.0) <.05 0.0 (-1.0-0.0)
RABL*
ACB/GTR
9.17±3.01 3.67±0.98 5.50±2.24
8.0 (6.0-15.0) 3.0 (3.0-6.0) <.01 5.0 (3.0-10.0)
ACB
9.92±2.71 4.00±1.13 5.92±1.83
10.0 (6.0-15.0) 4.0 (2.0-6.0) <.01 6.0 (3.0-9.0)
Data are expressed as the means ± standard deviation and medians (minimum-maximum).
ACB: autogenous cortical bone  GTR: guided tissue regeneration.
PPD: probing pocket depth  CAL: clinical attachment level  REC: gingival recession  RABL: radiological alveolar bone level.
*: No significant difference between the values of the groups (P>.05).
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number of clinical and experimental studies using 
ACB grafts for periodontal regenerative therapy 
in the recent years,11,13,46 an ACB graft is report-
edly osteoconductive but not osteogenic, because 
only few cells can survive.11,47 In an experimental 
study using a dog model with surgically created 
Class II furcation defects, periodontal healing was 
similar irrespective of the use of surgical debride-
ment alone, ACB grafting, or ACB grafting with a 
calcium sulfate barrier.11 Moreover, there is evi-
dence that the combination of an ACB graft and an 
enamel matrix derivative in the treatment of deep 
periodontal intraosseous defects leads to a signifi-
cant improvement in clinical parameters.13,46 
The results of the present study confirm the 
findings of a recent randomized controlled clini-
cal trial that evaluated the adjunctive effect of GTR 
using a polylactic acid barrier combined with au-
togenous bone grafting in the treatment of deep 
intrabony periodontal defects.48 Autogenous bone 
was harvested from the chin area in this study.48 
From the clinician's perspective, it is noteworthy 
that the PPD reduction and CAL gain in both the 
treatment modalities are somewhat greater than 
those in the previous study.48 The results obtained 
from this clinical study might have been influenced 
by the defect characteristics and center and/or op-
erator effect, which may depend on differences 
among the enrolled patients, technical ability, clin-
ical organization, and experience of the clinicians 
or a combination of these factors.49 
concLusIons
Within the limitations of the study, both ACB 
grafting with GTR and ACB grafting alone led to 
similar improvements in the clinical and radio-
graphic parameters at 6 months postoperatively, 
indicating that the combined approach does not 
provide an additional benefit over ACB grafting 
alone in the treatment of intraosseous periodontal 
defects. An ACB graft, which is particulate, easy to 
manipulate, and highly resorbable as well as does 
not need a second surgical site, can be selected 
alone for periodontal regenerative therapy. More-
over, an ACB graft is considered to be a useful re-
generative material for patients as it is cheaper 
than the other bone graft materials and complete-
ly safe, and eliminates concerns about disease 
transmission and immunogenic reactions associ-
ated with allogeneic or xenogeneic preparations.
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